文献速递脑血管病外科神经重症

波多黎各动脉瘤性与非动脉瘤性蛛网膜下腔出血的描述性研究及数字减影血管造影在非动脉瘤性蛛网膜下腔出血患者中的作用

Descriptive Study of Aneurysmal and Nonaneurysmal Subarachnoid Hemorrhage and the Role of Confirmative Digital Subtraction Angiography in Patients with Nonaneurysmal Subarachnoid in Puerto Rico.
PubMed 文献 · World Neurosurg · 2019-10-28

该研究回顾性分析2015至2018年波多黎各医学中心324例成人自发性蛛网膜下腔出血患者,比较动脉瘤性与非动脉瘤性亚组的临床特征与影像表现,并评估初次CTA阴性后DSA在非动脉瘤性蛛网膜下腔出血(尤其是中脑周围蛛网膜下腔出血)中的确认作用。

要点

  • 动脉瘤性蛛网膜下腔出血亚组急性脑积水、30天死亡率、弥漫性出血模式及Fisher和WFNS分级>2的比例更高。
  • 非动脉瘤性蛛网膜下腔出血患者慢性肾脏病和糖尿病患病率显著更高。
  • 初次CTA阴性的非动脉瘤性中脑周围蛛网膜下腔出血患者100%经DSA确认。

核心结论

  • 动脉瘤性蛛网膜下腔出血亚组与疾病负担增加相关。
  • 在作者所在人群中,低Fisher和WFNS分级且合并糖尿病和慢性肾脏病的非动脉瘤性中脑周围蛛网膜下腔出血患者,初次CTA阴性后可能不需要DSA。

研究设计与样本

  • 回顾性分析2015至2018年在波多黎各医学中心治疗的324例成人动脉瘤性和非动脉瘤性蛛网膜下腔出血患者的医疗记录。
  • 提取人口学、既往病史、临床特征和影像学信息。

主要发现

  • 动脉瘤性蛛网膜下腔出血亚组急性脑积水、30天死亡率、弥漫性蛛网膜下腔出血模式及初次检查Fisher和WFNS分级>2的比例更高。
  • 非动脉瘤性蛛网膜下腔出血患者慢性肾脏病和糖尿病患病率显著更高。
  • 初次CTA阴性的非动脉瘤性中脑周围蛛网膜下腔出血患者100%经DSA确认。

临床怎么用

  • 作者认为,在作者所在人群中,低Fisher和WFNS分级且合并糖尿病和慢性肾脏病的非动脉瘤性中脑周围蛛网膜下腔出血患者,初次CTA阴性后可能不需要DSA。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cerebrovascular disease is the fifth cause of mortality in Puerto Rico. There is no descriptive study for the presentation of spontaneous subarachnoid hemorrhage (SAH) in our institution. Therefore, our primary aim was to perform a retrospective analysis of adult patients with spontaneous SAH and assess the need for digital subtraction angiography (DSA) after initially aneurysm-negative computed tomography angiography (CTA) in nonaneurysmal SAH, specifically perimesencephalic SAH (PM-SAH). METHODS: Medical records of 324 adult patients with aneurysmal and nonaneurysmal SAH treated at the Puerto Rico Medical Center from 2015 to 2018 were retrospectively analyzed. Demographics, past medical history, clinical characteristics, and imaging information were extracted. RESULTS: Acute hydrocephalus, mortality at 30 days, prevalence of diffuse SAH pattern, and Fisher and World Federation of Neurosurgical Societies grades >2 on initial examination were higher in the aneurysmal SAH subgroup. Patients with nonaneurysmal SAH had a significantly higher prevalence of chronic kidney disease and diabetes mellitus. Of the patients with nonaneurysmal PM-SAH with initial aneurysm-negative CTA, 100% were subsequently confirmed by DSA. CONCLUSIONS: Patients in the aneurysmal SAH subgroup correlated with an increased disease burden. Furthermore, this study shows that in our population, patients with nonaneurysmal PM-SAH with a low Fisher and World Federation of Neurosurgical Societies grade and with comorbid diabetes mellitus and chronic kidney disease may not need DSA after a negative initial CTA result.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Flores G, Amaral-Nieves N, de Jesús A, et al. Descriptive Study of Aneurysmal and Nonaneurysmal Subarachnoid Hemorrhage and the Role of Confirmative Digital Subtraction Angiography in Patients with Nonaneurysmal Subarachnoid in Puerto Rico. World Neurosurg. 2019. PMID: 31672662. doi:10.1016/j.wneu.2019.10.104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。